Ehrke-Schulz E - Search Results

1

Muscle Specific Promotors for Gene Therapy - A Comparative Study in Proliferating and Differentiated Cells.

Dietz J, Jacobsen F, Zhuge H, Daya N, Bigot A, Zhang W, Ehrhardt A, Vorgerd M, Ehrke-Schulz E. Dietz J, et al. Among authors: ehrke schulz e. J Neuromuscul Dis. 2023;10(4):575-592. doi: 10.3233/JND-221574. J Neuromuscul Dis. 2023. PMID: 37270809 Free PMC article.

2

Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5.

Ehrke-Schulz E, Zhang W, Schiwon M, Bergmann T, Solanki M, Liu J, Boehme P, Leitner T, Ehrhardt A. Ehrke-Schulz E, et al. J Vis Exp. 2016 Jan 28;(107):e52894. doi: 10.3791/52894. J Vis Exp. 2016. PMID: 26863087 Free PMC article.

3

Quantification of designer nuclease induced mutation rates: a direct comparison of different methods.

Ehrke-Schulz E, Bergmann T, Schiwon M, Doerner J, Saydaminova K, Lieber A, Ehrhardt A. Ehrke-Schulz E, et al. Mol Ther Methods Clin Dev. 2016 Jul 6;3:16047. doi: 10.1038/mtm.2016.47. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 27419195 Free PMC article.

4

A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced Integration.

Boehme P, Zhang W, Solanki M, Ehrke-Schulz E, Ehrhardt A. Boehme P, et al. Mol Ther Nucleic Acids. 2016 Jul 19;5(7):e337. doi: 10.1038/mtna.2016.44. Mol Ther Nucleic Acids. 2016. PMID: 27434682 Free PMC article.

5

An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity.

Zhang W, Fu J, Liu J, Wang H, Schiwon M, Janz S, Schaffarczyk L, von der Goltz L, Ehrke-Schulz E, Dörner J, Solanki M, Boehme P, Bergmann T, Lieber A, Lauber C, Dahl A, Petzold A, Zhang Y, Stewart AF, Ehrhardt A. Zhang W, et al. Cell Rep. 2017 May 23;19(8):1698-1709. doi: 10.1016/j.celrep.2017.05.008. Cell Rep. 2017. PMID: 28538186 Free article.

6

Recent Advances in Preclinical Developments Using Adenovirus Hybrid Vectors.

Ehrke-Schulz E, Zhang W, Gao J, Ehrhardt A. Ehrke-Schulz E, et al. Hum Gene Ther. 2017 Oct;28(10):833-841. doi: 10.1089/hum.2017.140. Hum Gene Ther. 2017. PMID: 28854818 Review.

7

Establishment of the CRISPR/Cas9 System for Targeted Gene Disruption and Gene Tagging.

Ehrke-Schulz E, Schiwon M, Hagedorn C, Ehrhardt A. Ehrke-Schulz E, et al. Methods Mol Biol. 2017;1654:165-176. doi: 10.1007/978-1-4939-7231-9_11. Methods Mol Biol. 2017. PMID: 28986789

8

CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes.

Ehrke-Schulz E, Schiwon M, Leitner T, Dávid S, Bergmann T, Liu J, Ehrhardt A. Ehrke-Schulz E, et al. Sci Rep. 2017 Dec 7;7(1):17113. doi: 10.1038/s41598-017-17180-w. Sci Rep. 2017. PMID: 29215041 Free PMC article.

9

Designer nuclease-mediated gene correction via homology-directed repair in an in vitro model of canine hemophilia B.

Bergmann T, Ehrke-Schulz E, Gao J, Schiwon M, Schildgen V, David S, Schildgen O, Ehrhardt A. Bergmann T, et al. J Gene Med. 2018 May;20(5):e3020. doi: 10.1002/jgm.3020. Epub 2018 May 3. J Gene Med. 2018. PMID: 29608237

10

One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors.

Schiwon M, Ehrke-Schulz E, Oswald A, Bergmann T, Michler T, Protzer U, Ehrhardt A. Schiwon M, et al. Mol Ther Nucleic Acids. 2018 Sep 7;12:242-253. doi: 10.1016/j.omtn.2018.05.006. Epub 2018 Jun 7. Mol Ther Nucleic Acids. 2018. PMID: 30195763 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters